Zota Health Care LImited — Investor Meet, 03-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Zota Healthcare reported strong Q2 FY26 results. Revenue surged 92% YoY to ₹128.95 Cr, gross profit grew 112% to ₹76.50 Cr, and EBITDA turned positive at ₹7.96 Cr. Davaindia remains the core growth driver. The company reached 2,055 stores, aiming for 800 new COCO stores in FY26. A QIP up to ₹500 Cr is planned for Davaindia expansion. Footfalls are rising, and brand visibility is boosted by new ambassadors. Management is confident in disciplined expansion, expecting significant operating leverage from maturing stores by FY28, balancing current growth investments with future profitability for affordable healthcare access.